Table 1.
Clinical characteristics of 18 patients with gout enrolled in the study.
| No | Age (years) | Co-morbidities | Number of affected joints | Number of annual attacks | Therapy of attacks |
|---|---|---|---|---|---|
| 1 | 75 | DM2, VH, COPD | 2 | 2 | Colchicine |
| 2 | 80 | DM2, VH, CHD | 4 | 5 | Colchicine |
| 3 | 62 | DM2, VH, obesity | 1 | 1 | Colchicine |
| 4 | 80 | DM2, COPD, CHD | 1 | 1 | Colchicine |
| 5 | 45 | VH, obesity | 1 | 1 | Colchicine |
| 6 | 70 | VH | 1 | 1 | Colchicine |
| 7 | 67 | DM2, VH, CHD | 7 | 5 | NSAIDs |
| 8 | 65 | VH, obesity | 1 | 1 | Colchicine |
| 9 | 62 | VH | 1 | 1 | Colchicine |
| 10 | 55 | VH, obesity | 2 | 1 | Colchicine |
| 11 | 80 | DM2, VH | 2 | 2 | NSAIDs |
| 12 | 32 | Obesity | 4 | 6 | NSAIDs |
| 13 | 70 | VH | 1 | 1 | Colchicine |
| 14 | 70 | DM2, VH | 3 | 2 | Colchicine |
| 15 | 68 | Obesity | 1 | 3 | Colchicine |
| 16 | 52 | DM2, CRD | 1 | 10 | Colchicine |
| 17 | 69 | CRD | 5 | 4 | Colchicine |
| 18 | 46 | CRD | 1 | 5 | Colchicine |
CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; CRD, chronic renal disease; DM2, diabetes mellitus type 2; NSAIDs, non-steroidal anti-inflammatory drugs; VH, vascular hypertension.